Simcere Pharmaceutical Group Ltd
HKEX:2096

Watchlist Manager
Simcere Pharmaceutical Group Ltd Logo
Simcere Pharmaceutical Group Ltd
HKEX:2096
Watchlist
Price: 6.78 HKD 2.11% Market Closed
Market Cap: 17.1B HKD
Have any thoughts about
Simcere Pharmaceutical Group Ltd?
Write Note

Relative Value

The Relative Value of one Simcere Pharmaceutical Group Ltd stock under the Base Case scenario is 11.99 HKD. Compared to the current market price of 6.78 HKD, Simcere Pharmaceutical Group Ltd is Undervalued by 43%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
11.99 HKD
Undervaluation 43%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
66
vs Industry
51
Median 3Y
2.8
Median 5Y
3.2
Industry
2.5
Forward
2.4
vs History
vs Industry
25
Median 3Y
16
Median 5Y
16.9
Industry
21.8
Forward
16.8
vs History
56
vs Industry
4
Median 3Y
17.4
Median 5Y
16.8
Industry
16.1
vs History
9
vs Industry
17
Median 3Y
-8.2
Median 5Y
-12.6
Industry
23.8
vs History
64
vs Industry
40
Median 3Y
2.5
Median 5Y
2.9
Industry
2.1
vs History
70
vs Industry
53
Median 3Y
2.6
Median 5Y
2.8
Industry
2.7
Forward
2.1
vs History
70
vs Industry
64
Median 3Y
3.3
Median 5Y
3.6
Industry
5.2
vs History
72
vs Industry
29
Median 3Y
20.3
Median 5Y
21.5
Industry
13.5
Forward
10.2
vs History
84
vs Industry
24
Median 3Y
21.7
Median 5Y
27.3
Industry
16.8
Forward
13.1
vs History
58
vs Industry
4
Median 3Y
16.5
Median 5Y
15.7
Industry
15.2
vs History
1
vs Industry
18
Median 3Y
-14.1
Median 5Y
-36.8
Industry
19.3
vs History
68
vs Industry
45
Median 3Y
1.8
Median 5Y
2.1
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Simcere Pharmaceutical Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Simcere Pharmaceutical Group Ltd
HKEX:2096
17.2B HKD 2.6 -14.7 15.1 15.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
749.1B USD 18.5 89.9 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
348B USD 4 23.7 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
150.1B USD 2.5 35.4 10.5 15.9
P/E Multiple
Earnings Growth P/E to Growth
CN
Simcere Pharmaceutical Group Ltd
HKEX:2096
Average P/E: 32.3
Negative Multiple: -14.7
110%
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
89.9
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.7
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.4
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Simcere Pharmaceutical Group Ltd
HKEX:2096
Average EV/EBITDA: 415.1
15.1
91%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.1
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.5
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Simcere Pharmaceutical Group Ltd
HKEX:2096
Average EV/EBIT: 1 811.6
15.1
117%
0.1
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.7
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.9
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.9
68%
0.2

See Also

Discover More
Back to Top